- Home
- Slides
- Home
- Tools and Resources
- Research Summaries for Consumers, Clinicians, and Policymakers
- Search for Research Summaries, Reviews, and Reports
- Research Available for Comment
- Submit a Suggestion for Research
- Submit Scientific Information Packets
- Comparative Effectiveness Research Grant and ARRA Awards
- News and Announcements
- What Is Comparative Effectiveness Research
- Who Is Involved in the Effective Health Care Program
- What Is the Effective Health Care Program
Slides
Slides: 1–12 of 49
Clinical Questions Addressed by the CER (1 of 2)
Presentation: Analgesics for Osteoarthritis—An Update
Keywords: comparative effectiveness | systematic review | key question
Comparative Adverse Effects of Oral Agents: CV Effects
Presentation: Analgesics for Osteoarthritis—An Update
Keywords: comparative adverse effects | outcomes | strength of evidence | NSAIDs | CV risk
Angiotensin-Converting Enzyme Inhibitors (ACEIs), Angiotensin II Receptor Antagonists (ARBs), or Direct Renin Inhibitors (DRI) for Adults with Hypertension
Background: Prevalence
Background: Treatment
Background: Pharmacological Blockade of the Renin-Angiotensin System
Rationale for Update
Evidence of Benefits: Clinical Outcomes
Keywords: clinical outcomes | ACEIs | ARBs | mortality | cardiovascular events | serum lipid levels | renal disease | quality of life
Applicability Resources
Presentation: Assessing Applicability
Pharmacologic Effects of Antagonists on the Renin-Angiotensin-Aldosterone System
Identifying Trade-offs for Your Patients: Summary of Results on Comparative Effectiveness of Adding ACEIs and/or ARBs to Standard Medical Therapy
Your slide tray is being processed.